Binglan Yu Selected Research

Binglan Yu Research Topics

Disease

8	Pulmonary Hypertension 01/2020 - 03/2012
4	Hypertension (High Blood Pressure) 06/2017 - 04/2008
3	Methemoglobinemia 01/2022 - 04/2008
3	Melanoma (Melanoma, Malignant) 06/2004 - 04/2004
3	Vomiting 06/2004 - 04/2004
3	Nausea 06/2004 - 04/2004
2	Sickle Cell Anemia (Hemoglobin S Disease) 04/2022 - 01/2018
2	Heart Arrest (Cardiac Arrest) 01/2019 - 04/2014
2	Chronic Renal Insufficiency 11/2018 - 01/2018
2	Ischemia 04/2014 - 07/2012
2	Hypothermia 04/2014 - 04/2008
2	Open-Angle Glaucoma (Glaucoma, Open Angle) 04/2013 - 01/2013
2	Weight Loss (Weight Reduction) 06/2004 - 04/2004
1	Rheumatic Fever (Acute Articular Rheumatism) 11/2018
1	Acute Kidney Injury (Acute Renal Failure) 11/2018
1	Cardiomegaly (Heart Hypertrophy) 01/2018
1	Hypertrophy 01/2018
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2018
1	Hypophosphatemia 01/2018
1	Diabetes Mellitus 06/2017
1	Hyperlipidemias (Hyperlipidemia) 06/2017
1	Glaucoma 01/2017
1	Pneumonia (Pneumonitis) 11/2016
1	Atherosclerotic Plaque (Atheroma) 01/2016
1	Atherosclerosis 01/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2016
1	Vascular Diseases (Vascular Disease) 01/2016
1	Vascular Calcification 01/2016
1	Iron Overload 09/2014
1	Chronic Disease (Chronic Diseases) 04/2014
1	Anemia 04/2014
1	Brain Injuries (Brain Injury) 04/2014
1	Hypoxia (Hypoxemia) 11/2013
1	Optic Nerve Diseases (Optic Neuropathy) 01/2013
1	Hemorrhagic Shock 12/2012
1	Inflammation (Inflammations) 12/2012
1	Hemolysis 07/2012
1	Hyperemia 07/2012
1	Transfusion Reaction 01/2009
1	Body Weight (Weight, Body) 05/2004
1	Weight Gain 04/2004
1	Tyrosinemias (Tyrosinemia) 04/2004

Drug/Important Bio-Agent (IBA)

16	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020 - 04/2008
6	Hemoglobins (Hemoglobin)IBA 04/2022 - 04/2008
4	Oxygen (Dioxygen)IBA 01/2018 - 05/2004
3	MethemoglobinIBA 11/2018 - 04/2008
3	Tyrosine (L-Tyrosine)FDA Link 06/2004 - 04/2004
2	Oxyhemoglobins (Oxyhemoglobin)IBA 11/2018 - 11/2016
2	IridiumIBA 11/2016 - 07/2015
2	HepcidinsIBA 09/2014 - 04/2014
2	Soluble Guanylyl CyclaseIBA 04/2013 - 01/2013
2	HBOC 201 (Hemopure)IBA 01/2009 - 04/2008
2	Monophenol Monooxygenase (Tyrosinase)IBA 06/2004 - 04/2004
1	Nitrogen DioxideIBA 01/2022
1	NitrogenIBA 11/2018
1	CalcineurinIBA 01/2018
1	Fibroblast Growth Factor-23IBA 01/2018
1	Contrast MediaIBA 01/2018
1	DisulfidesIBA 01/2018
1	Phosphates (Orthophosphate)IBA 01/2018
1	Protons (Proton)IBA 01/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	TriazolesIBA 01/2018
1	Therapeutic UsesIBA 01/2018
1	HemopexinIBA 06/2017
1	HaptoglobinsIBA 06/2017
1	PlatinumIBA 11/2016
1	LipidsIBA 01/2016
1	Type II Bone Morphogenetic Protein Receptors (Bone Morphogenetic Protein Receptor Type II)IBA 09/2014
1	IronIBA 04/2014
1	Interleukin-6 (Interleukin 6)IBA 04/2014
1	Hormones (Hormone)IBA 04/2014
1	Dihydrotachysterol (AT 10)IBA 04/2014
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 11/2013
1	Retinaldehyde (Retinal)IBA 01/2013
1	Lactic Acid (Lactate)FDA LinkGeneric 12/2012
1	NitritesIBA 07/2012
1	PolyHemeIBA 03/2010
1	polymerized bovine hemoglobinIBA 01/2009
1	Sodium NitriteIBA 04/2008
1	Blood Substitutes (Artificial Blood)IBA 04/2008
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 04/2008
1	polyhemoglobin-tyrosinaseIBA 05/2004
1	Capsules (Microcapsules)IBA 04/2004

Therapy/Procedure

4	Therapeutics 01/2018 - 07/2015
2	Intravenous Injections 06/2004 - 05/2004
1	Catheters 01/2020
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 11/2018
1	Electrodes (Electrode) 07/2015
1	Induced Hypothermia 04/2014
1	Cardiopulmonary Resuscitation (CPR) 04/2014
1	Resuscitation 12/2012
1	Blood Transfusion (Blood Transfusions) 01/2009
1	Intravenous Administration 04/2008
1	Intravenous Infusions 04/2008
1	Diet Therapy (Therapy, Diet) 04/2004